Which GLP-1 Telehealth Companies Are Best? See Top Picks From US News & World Report
- U.S. News & World Report released its first ratings for telehealth platforms offering GLP-1 drugs on August 12.
- About 11% of Americans are currently using GLP-1 medications for weight loss, according to Gallup.
- The ratings evaluated 20 telehealth companies based on six metrics, including clinical support and customer satisfaction.
- The top-rated companies included Amazon One Medical, Found, and Ro, with scores ranging from 3.9 to 4.8 on a five-point scale.
- Experts have raised concerns about the level of medical support provided by some telehealth platforms.
People looking to lose weight with GLP-1 drugs can choose from a growing number of telehealth companies that offer these medications online. U.S. News & World Report unveiled its first ratings for the best telehealth platforms for GLP-1s on August 12, highlighting the increasing popularity of these drugs among Americans.
The ratings focused on 20 companies providing access to FDA-approved GLP-1 drugs and assessed them based on metrics such as clinical support, screening rigor, and customer satisfaction. Notably, 11 companies received high ratings, with Amazon One Medical achieving a score of 4.8, followed by Found and Ro.
Concerns have been raised regarding the medical oversight and support available through some telehealth platforms, with experts warning that some services may prioritize quick prescriptions over comprehensive care. The ratings aim to help consumers make informed decisions when seeking GLP-1 medications through telehealth options.
哪些GLP-1远程医疗公司最好？请查看美国新闻与世界报道的最佳选择
希望通过GLP-1药物减肥的人可以选择越来越多的提供这些药物的远程医疗公司。美国新闻与世界报道于8月12日发布了针对GLP-1远程医疗平台的首次评级，突显了这些药物在美国人中日益增长的受欢迎程度。
评级聚焦于20家提供FDA批准的GLP-1药物的公司，并基于临床支持、筛查严格性和客户满意度等指标对其进行评估。值得注意的是，11家公司获得了高分，其中亚马逊一医疗的得分为4.8，紧随其后的是Found和Ro。
专家对某些远程医疗平台提供的医疗监督和支持水平表示担忧，警告称某些服务可能更注重快速开处方而非全面护理。这些评级旨在帮助消费者在通过远程医疗选项寻求GLP-1药物时做出明智的决定。